Point72 Asset Management L.P. 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:15 pm Sale |
2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Point72 Asset Management L.P. | 30,702 0.100% |
-2,037,172 (-98.52%) |
Filing |
| 2022-06-22 4:14 pm Purchase |
2022-06-21 | 13G | Fulcrum Therapeutics, Inc. FULC |
Point72 Asset Management L.P. | 2,067,874 5.100% |
729,206 (+54.47%) |
Filing |
| 2021-02-16 3:22 pm Sale |
2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Point72 Asset Management L.P. | 1,338,668 4.900% |
-43,340 (-3.14%) |
Filing |
| 2020-09-18 5:21 pm Purchase |
2020-09-17 | 13G | Fulcrum Therapeutics, Inc. FULC |
Point72 Asset Management L.P. | 1,382,008 5.000% |
1,382,008 (New Position) |
Filing |